HMGB1 and breast cancer: Both TLR4, expressed on APC, and HMGB1 are required for ICD and for efficient immune stimulation as demonstrated in experiments neutralizing HMGB1 [80] and in breast cancer patients having a loss-of-function TLR4 allele exhibiting reduced binding affinity for HMGB1.